Compass Therapeutics (CMPX) Current Leases (2021 - 2026)
Compass Therapeutics (CMPX) posted Current Leases of $1.4 million for Q1 2026, up 37.3% sequentially from $1.0 million in Q4 2025, and up 1159.63% YoY from $109000.0 in Q1 2025.
Compass Therapeutics (CMPX) Current Leases (2021 - 2026) Analysis & Trends
Compass Therapeutics has reported Current Leases for 6 years, with the latest figure at $1.4 million in Q1 2026.
- Quarterly Current Leases rose 1159.63% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 1159.63% YoY) and the FY2025 annual result came in at $1.0 million, up 195.86% from the prior year.
- Current Leases rose to $1.4 million in Q1 2026 per CMPX's latest filing, from $1.0 million in the prior quarter.
- Over five years, Current Leases peaked at $1.4 million in Q1 2026 and troughed at $109000.0 in Q1 2025.
- A 5-year average of $932352.9 and a median of $1.1 million in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2025 and 2026: Current Leases tumbled 91.09% in 2025, then surged 1159.63% in 2026.
- Over 5 years, Current Leases stood at $1.1 million in 2022, then gained by 9.12% to $1.2 million in 2023, then plunged by 71.76% to $338000.0 in 2024, then jumped by 195.86% to $1.0 million in 2025, then surged by 37.3% to $1.4 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.4 million, $1.0 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | 1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 271,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 338,000.00 |
| Sep 30, 2024 | 557,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 989,000.00 |
| Sep 30, 2021 | 1.07 Mn |